Report Detail

Other Global Gene Therapies for Cancer Treatment Market Growth (Status and Outlook) 2019-2024

  • RnM3128259
  • |
  • 28 March, 2019
  • |
  • Global
  • |
  • 119 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.
In the last several years, global market of Gene Therapies for Cancer Treatment developed rapidly, with an average growth rate of 199%. In 2018, global revenue of Gene Therapies for Cancer Treatment is 445 million USD. The rising prevalence rate of cancer has been a huge challenge for the global economies as the disease leads to high rate of mortality and economic losses. The current treatment options available come with many drawbacks such as severe side effects and relapse of cancer. These factors have led to high investment in the R&D for development of various novel therapies with cancer gene therapy being one of the major ones of them.
The classification of Gene Therapies for Cancer Treatment includes Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer, and most of Gene Therapies for Cancer Treatment is Gene Induced Immunotherapy, the proportion of Biopsy in 2018 is about 78%.
ene Therapies for Cancer Treatment is widely used in Hospital, Clinic and other. The most proportion of Gene Therapies for Cancer Treatment is used in Hospital, and the proportion is about 68.3% in 2018.

According to this study, over the next five years the Gene Therapies for Cancer Treatment market will register a 67.3% CAGR in terms of revenue, the global market size will reach US$ 25300 million by 2024, from US$ 1940 million in 2019. In particular, this report presents the global revenue market share of key companies in Gene Therapies for Cancer Treatment business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Gene Therapies for Cancer Treatment market by product type, application, key companies and key regions.

This study considers the Gene Therapies for Cancer Treatment value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Gene Induced Immunotherapy
Oncolytic Virotherapy
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital
Clinic
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
Kite Pharma
Amgen
Shanghai Sunway
Sibiono
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Gene Therapies for Cancer Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Gene Therapies for Cancer Treatment market by identifying its various subsegments.
Focuses on the key global Gene Therapies for Cancer Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gene Therapies for Cancer Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Gene Therapies for Cancer Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Gene Therapies for Cancer Treatment Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Gene Therapies for Cancer Treatment Market Size 2014-2024
        • 2.1.2 Gene Therapies for Cancer Treatment Market Size CAGR by Region
      • 2.2 Gene Therapies for Cancer Treatment Segment by Type
        • 2.2.1 Gene Induced Immunotherapy
        • 2.2.2 Oncolytic Virotherapy
        • 2.2.3 Gene Transfer
      • 2.3 Gene Therapies for Cancer Treatment Market Size by Type
        • 2.3.1 Global Gene Therapies for Cancer Treatment Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type (2014-2019)
      • 2.4 Gene Therapies for Cancer Treatment Segment by Application
        • 2.4.1 Hospital
        • 2.4.2 Clinic
        • 2.4.3 Other
      • 2.5 Gene Therapies for Cancer Treatment Market Size by Application
        • 2.5.1 Global Gene Therapies for Cancer Treatment Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Application (2014-2019)

      3 Global Gene Therapies for Cancer Treatment by Players

      • 3.1 Global Gene Therapies for Cancer Treatment Market Size Market Share by Players
        • 3.1.1 Global Gene Therapies for Cancer Treatment Market Size by Players (2017-2019)
        • 3.1.2 Global Gene Therapies for Cancer Treatment Market Size Market Share by Players (2017-2019)
      • 3.2 Global Gene Therapies for Cancer Treatment Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Gene Therapies for Cancer Treatment by Regions

      • 4.1 Gene Therapies for Cancer Treatment Market Size by Regions
      • 4.2 Americas Gene Therapies for Cancer Treatment Market Size Growth
      • 4.3 APAC Gene Therapies for Cancer Treatment Market Size Growth
      • 4.4 Europe Gene Therapies for Cancer Treatment Market Size Growth
      • 4.5 Middle East & Africa Gene Therapies for Cancer Treatment Market Size Growth

      5 Americas

      • 5.1 Americas Gene Therapies for Cancer Treatment Market Size by Countries
      • 5.2 Americas Gene Therapies for Cancer Treatment Market Size by Type
      • 5.3 Americas Gene Therapies for Cancer Treatment Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Gene Therapies for Cancer Treatment Market Size by Countries
      • 6.2 APAC Gene Therapies for Cancer Treatment Market Size by Type
      • 6.3 APAC Gene Therapies for Cancer Treatment Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Gene Therapies for Cancer Treatment by Countries
      • 7.2 Europe Gene Therapies for Cancer Treatment Market Size by Type
      • 7.3 Europe Gene Therapies for Cancer Treatment Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Gene Therapies for Cancer Treatment by Countries
      • 8.2 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Type
      • 8.3 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Gene Therapies for Cancer Treatment Market Forecast

      • 10.1 Global Gene Therapies for Cancer Treatment Market Size Forecast (2019-2024)
      • 10.2 Global Gene Therapies for Cancer Treatment Forecast by Regions
        • 10.2.1 Global Gene Therapies for Cancer Treatment Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Gene Therapies for Cancer Treatment Forecast by Type
      • 10.8 Global Gene Therapies for Cancer Treatment Forecast by Application

      11 Key Players Analysis

      • 11.1 Novartis
        • 11.1.1 Company Details
        • 11.1.2 Gene Therapies for Cancer Treatment Product Offered
        • 11.1.3 Novartis Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Novartis News
      • 11.2 Kite Pharma
        • 11.2.1 Company Details
        • 11.2.2 Gene Therapies for Cancer Treatment Product Offered
        • 11.2.3 Kite Pharma Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Kite Pharma News
      • 11.3 Amgen
        • 11.3.1 Company Details
        • 11.3.2 Gene Therapies for Cancer Treatment Product Offered
        • 11.3.3 Amgen Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Amgen News
      • 11.4 Shanghai Sunway
        • 11.4.1 Company Details
        • 11.4.2 Gene Therapies for Cancer Treatment Product Offered
        • 11.4.3 Shanghai Sunway Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Shanghai Sunway News
      • 11.5 Sibiono
        • 11.5.1 Company Details
        • 11.5.2 Gene Therapies for Cancer Treatment Product Offered
        • 11.5.3 Sibiono Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Sibiono News

      ...

        12 Research Findings and Conclusion

        Summary:
        Get latest Market Research Reports on Gene Therapies for Cancer Treatment . Industry analysis & Market Report on Gene Therapies for Cancer Treatment is a syndicated market report, published as Global Gene Therapies for Cancer Treatment Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Gene Therapies for Cancer Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,660.00
        $5,490.00
        $7,320.00
        2,898.72
        4,348.08
        5,797.44
        3,389.16
        5,083.74
        6,778.32
        553,941.00
        830,911.50
        1,107,882.00
        305,244.00
        457,866.00
        610,488.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report